Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in c
Author: ["Shi Du Yan","Shi Fang Yan","Xi Chen","Jin Fu","Ming Chen","Periannan Kuppusamy","Mark A. Smith","George Perry","Gabriel C. Godman","Peter Nawroth","Jay L. Zweier","David Stern"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Paired helical filament (PHF) tau is the principal component of neurofibriliary tangles, a characteristic feature of the neurodegenerative pathology in Alzheimer's disease (AD). Post-translational modification of tau, especially phosphorylation, has been considered a major factor in aggregation and diminished microtubule interactions of PHF-tau. Recently, it has been recognized that PHF-tau is also subject to non-enzymatic glycation, with formation of advanced glycation end products (AGEs). We now show that as a consequence of glycation, PHF-tau from AD and AGE-tau generate oxygen free radicals, thereby activating transcription via nuclear factor-κB, increasing amyloid β-protein precursor and release of ∼4 kD amyloid β-peptides. These data provide insight into how PHF-tau disturbs neuronal function, and add to a growing body of evidence that oxidant stress contributes to the pathogenesis of AD.
Cite this article
Yan, S., Yan, S., Chen, X. et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat Med 1, 693–699 (1995). https://doi.org/10.1038/nm0795-693